“We are delighted to be able to launch Remsima SC today and to bring the first and only subcutaneous form of infliximab to patients, payers and clinicians in Canada,” said Jovan Antunovic, commercial director at Celltrion Healthcare Canada. “Our team is strong, growing and proud that Rem...